Company intelligence / Profile preview

Datrix

Milan, Italy

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Datrix develops and applies proprietary AI and Augmented Analytics technology across verticals, including life science and healthcare, supporting R&D projects in collaboration with academic and industry partners; no clinical results as the company is not a drug developer.

Modalities: AI-based analytic toolsplatform tools
Industry: Drug Discovery Services

Partnerships

International R&D consortia, including projects funded by the EU and Italy in life science and healthcare AIBNP Paribas for the WellMakers wellbeing platform

Beyond the preview

Go deeper on Datrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Datrix.

Explore the full profile